The Drug Controller General of India from next month will issue Certificates of Pharmaceutical Products (CoPP) and Certificates of Good Manufacturing Practice for medicinal products required for exports.
In a letter to various stake holders, DCGI said, "a considered view has been taken that Certificate of Pharmaceutical Products (CoPP) and Certificate of Good Manufacturing Practise (GMP) under WHO certification shall be taken over by the National Regulatory Authority ie DCGI office."
The notification on the centralisation of the process said both the CoPPs and the GMPs would be issued from October 1 by the national drug regulator.
The CoPP is mandatory in many countries that require World Health Organisation (WHO) accreditation for pharmaceutical products being imported. As laid down by the WHO, the GMP certification is also necessary for the same.
The decision was made in 40th drug consultative committee (DCC) meeting held in June, after WHO raised several issues over the issuance of these certificates.
"The WHO has time and again expressed concerns on the implementation of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce," the letter said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
